Home » Topics » BioWorld Science

BioWorld Science
RSS

Tiziana presents phase I results for nasal foralumab

Sep. 12, 2019

Molecular Partners initiates first-in-human study of MP-0310

Sep. 12, 2019

Murine model reveals TRPA1 loss is involved in age-related dilated cardiomyopathy

Sep. 12, 2019

Pfizer reports preliminary data from phase II pediatric study of 20vPnC candidate

Sep. 10, 2019

Translate Bio discontinues MRT-5201 for OTC deficiency, prioritizes pulmonary disease programs

Sep. 10, 2019

Alector begins phase II study of AL-001 for frontotemporal dementia

Sep. 10, 2019

Prometic initiates phase I study of PBI-4547

Sep. 10, 2019

Phase II study of bryostatin-1 in moderate to severe Alzheimer's misses primary endpoint

Sep. 10, 2019

Phase II data on contezolid acefosamil in ABSSSI support progression to phase III trials

Sep. 10, 2019

Potential target identified for leukemia treatment

Sep. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...